carbidopa, levodopa drug combination has been researched along with Muscle Weakness in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eng, JJ; Inkster, LM; MacIntyre, DL; Stoessl, AJ | 1 |
Ko, CH; Kong, CK; Lam, CW; Tong, SF | 1 |
2 other study(ies) available for carbidopa, levodopa drug combination and Muscle Weakness
Article | Year |
---|---|
Leg muscle strength is reduced in Parkinson's disease and relates to the ability to rise from a chair.
Topics: Antiparkinson Agents; Carbidopa; Disability Evaluation; Drug Combinations; Female; Hip; Humans; Knee; Levodopa; Lower Extremity; Male; Middle Aged; Muscle Weakness; Muscle, Skeletal; Parkinson Disease; Posture; Random Allocation; Severity of Illness Index | 2003 |
Atypical presentation of dopa-responsive dystonia: generalized hypotonia and proximal weakness.
Topics: Carbidopa; Child; Chromosome Aberrations; Chromosome Disorders; Circadian Rhythm; Drug Combinations; Dystonic Disorders; Gait; Genes, Dominant; GTP Cyclohydrolase; Humans; Levodopa; Male; Muscle Hypotonia; Muscle Weakness; Neurologic Examination; Point Mutation; Treatment Outcome | 2001 |